Capecitabine Tablets, 500 mg
- Manufacturer
- Prodigy Innovation, LLC.
- Effective date
- 2019-04-21
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:24
Label at a glance#
ProductCapecitabine Tablets, 150 mg
Active ingredientCAPECITABINE
Label structure1 sections
Label contents#
Full prescribing information#
DailyMed RxNorm Mappings#
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| CAPECITABINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a5eae620-c3a7-41bb-55a8-fce9c3eb9864 | Product name | 9 | 20180820 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70297-003-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-58e3-a910-e053-dadaa90a0b85 | Capecitabine Tablets, USP 150 mg and 500 mg |
| 70297-004-02 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-58e3-a910-e053-dadaa90a0b85 | Capecitabine Tablets, USP 150 mg and 500 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70297-003-02 | Capecitabine Tablets, 150 mg | 25000 in 1 BAG | TABLET | 25000 | 1 | |
| 70297-004-02 | Capecitabine Tablets, 500 mg | 25000 in 1 BAG | TABLET | 25000 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70297-003 | CAPECITABINE TABLETS, 150 MG TABLET CAPECITABINE TABLETS, 500 MG TABLET [PRODIGY INNOVATION, LLC.] | 1 | 1 package rows | 20190501_87173e7c-6e29-2e85-e053-2a91aa0ae4ae.zip |
| 70297-004 | CAPECITABINE TABLETS, 150 MG TABLET CAPECITABINE TABLETS, 500 MG TABLET [PRODIGY INNOVATION, LLC.] | 1 | 1 package rows | 20190501_87173e7c-6e29-2e85-e053-2a91aa0ae4ae.zip |
Products#
Every source-derived product name is available through these pages.
- Capecitabine Tablets, 150 mg
- CAPECITABINE
- MICROCRYSTALLINE CELLULOSE 102
- LACTOSE MONOHYDRATE
- ANHYDROUS LACTOSE
- CROSCARMELLOSE SODIUM
- CROSCARMELLOSE
- MAGNESIUM STEARATE
- Capecitabine Tablets, 500 mg
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 70297-003 | 70297-003-02 |
| 70297-004 | 70297-004-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CAPECITABINE | 6804DJ8Z9U | ACTIB |
| MICROCRYSTALLINE CELLULOSE 102 | PNR0YF693Y | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MICROCRYSTALLINE CELLULOSE 102 | PNR0YF693Y | IACT |
| CAPECITABINE | 6804DJ8Z9U | ACTIB |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 87173e7c-6e2a-2e85-e053-2a91aa0ae4ae | 87173e7c-6e29-2e85-e053-2a91aa0ae4ae | 2019-04-21 | 87173e7c-6e2a-2e85-e053-2a91aa0ae4ae 87173e7c-6e29-2e85-e053-2a91aa0ae4ae |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

